Cargando…

Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis

Detalles Bibliográficos
Autores principales: Trepanowski, Nicole, Yim, Rebecca M., Wetstone, Rachel, MacDonald, Elizabeth, Servattalab, Sarah, Jacob-George, Subin, Harris, John E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641553/
https://www.ncbi.nlm.nih.gov/pubmed/37965188
http://dx.doi.org/10.1016/j.jdcr.2023.09.033
_version_ 1785146794286514176
author Trepanowski, Nicole
Yim, Rebecca M.
Wetstone, Rachel
MacDonald, Elizabeth
Servattalab, Sarah
Jacob-George, Subin
Harris, John E.
author_facet Trepanowski, Nicole
Yim, Rebecca M.
Wetstone, Rachel
MacDonald, Elizabeth
Servattalab, Sarah
Jacob-George, Subin
Harris, John E.
author_sort Trepanowski, Nicole
collection PubMed
description
format Online
Article
Text
id pubmed-10641553
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106415532023-11-14 Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis Trepanowski, Nicole Yim, Rebecca M. Wetstone, Rachel MacDonald, Elizabeth Servattalab, Sarah Jacob-George, Subin Harris, John E. JAAD Case Rep Case Report Elsevier 2023-10-11 /pmc/articles/PMC10641553/ /pubmed/37965188 http://dx.doi.org/10.1016/j.jdcr.2023.09.033 Text en © 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Trepanowski, Nicole
Yim, Rebecca M.
Wetstone, Rachel
MacDonald, Elizabeth
Servattalab, Sarah
Jacob-George, Subin
Harris, John E.
Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
title Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
title_full Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
title_fullStr Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
title_full_unstemmed Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
title_short Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
title_sort vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641553/
https://www.ncbi.nlm.nih.gov/pubmed/37965188
http://dx.doi.org/10.1016/j.jdcr.2023.09.033
work_keys_str_mv AT trepanowskinicole vitiligoprogressioninapatientundergoingromosozumabtreatmentforosteoporosis
AT yimrebeccam vitiligoprogressioninapatientundergoingromosozumabtreatmentforosteoporosis
AT wetstonerachel vitiligoprogressioninapatientundergoingromosozumabtreatmentforosteoporosis
AT macdonaldelizabeth vitiligoprogressioninapatientundergoingromosozumabtreatmentforosteoporosis
AT servattalabsarah vitiligoprogressioninapatientundergoingromosozumabtreatmentforosteoporosis
AT jacobgeorgesubin vitiligoprogressioninapatientundergoingromosozumabtreatmentforosteoporosis
AT harrisjohne vitiligoprogressioninapatientundergoingromosozumabtreatmentforosteoporosis